Axar.Az Logo

BioNTech aims to supply 2B COVID-19 vaccine doses this year

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The German pharma company BioNTech announced Monday that it is boosting its manufacturing capacity to be able to supply 2 billion doses of the coronavirus vaccine this year. reports that Dr. Ugur Sahin, the co-founder of BioNTech, gave details about the new investment plans of his company and its American partner Pfizer, in a presentation posted on the company's website.

“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021,” he said.

“This is based on continuous process improvements and expansion at our current facilities, and contingent upon adding more suppliers as well as contract manufacturers,” he noted.

BioNTech, which has developed the world’s first effective jab against COVID-19, is currently producing the vaccines together with Pfizer in three manufacturing sites in the US and two other production facilities in Europe.

2021.01.11 / 21:14
See also

WHO doesn’t recommend introducing Covid passports for now

Senegal receives 324,000 doses of AstraZeneca vaccine

There is no East and West vaccine, there is good and bad

WHO to allocate 227M COVAX shots by end of May

Russia’s Sputnik V vaccine registered in Slovakia

US regulator approves Johnson&Johnson coronavirus vaccine

WHO reports over 420,000 new daily cases of COVID-19

Global COVID-19 deaths surpass 2.5 mln

Johnson & Johnson's one-dose vaccine closes in on U.S. approval

World's first doses of Covax vaccines delivered

Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla